Chapter 4. Large-Scale Applications of Biocatalysis in the Asymmetric Synthesis of Laboratory Chemicals
- Dr. Hans-Ulrich Blaser2,
- Dr. Elke Schmidt3
Published Online: 13 JAN 2004
DOI: 10.1002/3527602151.ch17
Copyright © 2004 Wiley-VCH Verlag GmbH & Co. KGaA
Book Title

Asymmetric Catalysis on Industrial Scale: Challenges, Approaches and Solutions
Additional Information
How to Cite
Wohlgemuth, R. (2004) Large-Scale Applications of Biocatalysis in the Asymmetric Synthesis of Laboratory Chemicals, in Asymmetric Catalysis on Industrial Scale: Challenges, Approaches and Solutions (eds H.-U. Blaser and E. Schmidt), Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, FRG. doi: 10.1002/3527602151.ch17
Editor Information
- 2
Solvias AG, P.O. Box, CH-4002 Basel, Switzerland
- 3
Syngenta Crop Protection AG, CH-4058 Basel, Switzerland
Publication History
- Published Online: 13 JAN 2004
- Published Print: 6 NOV 2003
ISBN Information
Print ISBN: 9783527306312
Online ISBN: 9783527602155
- Summary
- Chapter
Keywords:
- biocatalysis;
- asymmetric synthesis;
- laboratory chemicals;
- Fluka;
- racemic mixtures;
- protecting groups;
- biocatalysts;
- octanol;
- Baeyer-Villiger reaction
Summary
This chapter contains sections titled:
Introduction
History of Applied Biocatalysis at Fluka
Resolution of Racemic Mixtures
Resolution of Racemic Amino Acids
Resolution of Racemic Alcohols
Decomposition Reactions of Educts and Side Products
Introduction and Removal of Protecting Groups
Development and Production of Biocatalysts
Complex Reaction Paths to Natural Products
Regio- and Stereoselective Synthesis
Reasons for Large-Scale Application of Biocatalysts for the Synthesis of Laboratory Chemicals
Examples of Large-Scale Application of Biocatalysis
Matrix Approach: Product Groups Produced with Specific Enzyme Classes
(S)-2-Octanol
(R)-2-Octanol
Comparison of Classical Resolution with the Biocatalytic Procedure
2-Oxabicyclo[3.3.0]-oct-6-en-3-one
3-Oxabicyclo[3.3.0]-oct-6-en-2-one
Comparison of the Classical Procedure with the Biocatalytic Baeyer-Villiger Reaction
Discussion and Outlook
